Keiji Fukuda

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Dr. Keiji Fukuda‏‎ is director and a clinical professor at The University of Hong Kong School of Public Health. He previously worked for the CDC and the WHO.

Early life and education[edit | edit source]

Dr. Fukuda earned a BA from Oberlin College,[1] where he studied biology,[2] his MD from the University of Vermont,[1] and an MPH from the University of California, Berkeley.[1] He is board-certified in internal medicine.[2]

Career[edit | edit source]

Dr. Fukuda's early career focused on chronic fatigue syndrome,[1] establishing the Fukuda criteria.

Dr. Fukuda also served as medical epidemiologist in the Viral Exanthems and Herpesvirus Branch of the U.S. National Center for Infectious Diseases[2] and as Chief of Epidemiology in the Influenza Branch of the U.S. Centers for Disease Control and Prevention Centers (CDC).[1] From 2005 to 2016, he worked for the World Health Organization (WHO), serving as Scientist, Coordinator and then Director of the Global Influenza Programme (2005-2008), Assistant Director-General for Health Security and Environment ad interim (2008-2009), Special Adviser on Pandemic Influenza to the Director-General (2009-2010), Assistant Director-General for Health Security (2010-2015) and Special Representative for Antimicrobial Resistance for the Director-General (2015-2016).[1]

Dr. Fukuda currently serves as director and a clinical professor at The University of Hong Kong School of Public Health.[1] In October 2020, senior management team of the University of Hong Kong decided not to renew his contract. Keiji will thus leave the University of Hong Kong in late 2021.

References[edit | edit source]

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 "Fukuda, Keiji". sph.hku.hk. Retrieved January 11, 2019.
  2. 2.0 2.1 2.2 "Keiji Fukuda, M.D., Ph.D. : Health and Medicine Division". nationalacademies.org. Retrieved January 11, 2019.